Condition
Malignant Pleural Mesothelioma (MPM)|Choroidal Nevus|Primary Uveal Melanoma (UM)|Metastatic Uveal Melanoma (UM)|Renal Cell Carcinoma|Cholangiocarcinoma
Estimated Enrollment: 460
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective
Study ID Numbers: 12-235
Study First Received: January 18, 2013
Last Updated: January 27, 2017
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
determine the prevalence of germline BAP1 mutations|prevalence of somatic BAP1 mutations in disease mesothelioma and metastatic uveal melanoma.
Sponsors and Collaborators:
Memorial Sloan Kettering Cancer Center|United States Department of Defense
Website Link: https://ClinicalTrials.gov/show/NCT01773655
